Psyence Biomedical
PBM
10 hedge funds and large institutions have $2.34M invested in Psyence Biomedical in 2026 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
366% more capital inflows, than outflows
Capital inflows: $567K | Capital outflows: $122K
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
11% more funds holding
Funds holding: 9 → 10 (+1)
2.76% more ownership
Funds ownership: 9.66% → 12.42% (+2.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AdvisorShares Investments
Bethesda,
Maryland
|
+$558K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$7.24K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.1K |
| 4 |
Rockefeller Capital Management
New York
|
+$962 |
| 5 |
JP Morgan Chase
New York
|
+$45 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$58.1K |
| 2 |
XTX Topco
George Town,
Cayman Islands
|
-$46.2K |
| 3 |
Morgan Stanley
New York
|
-$17.4K |
PBM Hedge Fund Activity: Q3 2026 in Review
10 of the 8,184 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical (PBM) for Q3 2026, worth a combined $2.34M — up 88% from $1.24M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PBM positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was AdvisorShares Investments, adding an estimated $558K. The largest seller was Jane Street, cutting an estimated $58.1K.
- 10 institutional investors held Psyence Biomedical (PBM) as of Q3 2026, up from 9 in Q2 2026.
- Funds reported $2.34M of Psyence Biomedical stock for Q3 2026, up 88% quarter-over-quarter.
- 2 funds opened new Psyence Biomedical positions in Q3 2026 and 1 closed out, a net change of +1 holder.
- The largest Psyence Biomedical buyer in Q3 2026 was AdvisorShares Investments, an estimated $558K added.
- The largest Psyence Biomedical seller in Q3 2026 was Jane Street, an estimated $58.1K sold.
Based on aggregated 13F filings for Q3 2026.